Eri Taguchi

441 total citations
11 papers, 367 citations indexed

About

Eri Taguchi is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eri Taguchi has authored 11 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eri Taguchi's work include Angiogenesis and VEGF in Cancer (6 papers), HER2/EGFR in Cancer Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Eri Taguchi is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), HER2/EGFR in Cancer Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Eri Taguchi collaborates with scholars based in Japan and United States. Eri Taguchi's co-authors include Kazuhide Nakamura, Masabumi Shibuya, Kazuo Kubo, Junichi Enokizono, Koki Hasegawa, Toshiyuki Isoe, Atsushi Yamamoto, Francis Bichat, R Suzuki and Toru Miura and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Controlled Release.

In The Last Decade

Eri Taguchi

11 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eri Taguchi Japan 7 219 119 95 83 79 11 367
J. C. Bendell United States 13 261 1.2× 208 1.7× 82 0.9× 50 0.6× 54 0.7× 37 413
Sinto Sebastian United States 8 265 1.2× 188 1.6× 50 0.5× 51 0.6× 67 0.8× 11 412
Christopher Montemagno France 14 196 0.9× 169 1.4× 105 1.1× 86 1.0× 92 1.2× 31 453
Atsushi Yawata Japan 10 353 1.6× 131 1.1× 50 0.5× 18 0.2× 85 1.1× 22 572
Michael W. Boesgaard Denmark 11 130 0.6× 268 2.3× 37 0.4× 28 0.3× 108 1.4× 13 467
Jeffrey E. Lehr United States 7 308 1.4× 169 1.4× 120 1.3× 32 0.4× 70 0.9× 9 494
Sean E. Sissons United States 8 242 1.1× 201 1.7× 75 0.8× 29 0.3× 145 1.8× 11 476
Adrian Staab Germany 9 255 1.2× 61 0.5× 51 0.5× 37 0.4× 210 2.7× 10 428
Sandra Ictech United States 9 184 0.8× 102 0.9× 180 1.9× 38 0.5× 70 0.9× 12 469
Amélie Petitprez France 6 178 0.8× 159 1.3× 122 1.3× 28 0.3× 75 0.9× 6 334

Countries citing papers authored by Eri Taguchi

Since Specialization
Citations

This map shows the geographic impact of Eri Taguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Taguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Taguchi more than expected).

Fields of papers citing papers by Eri Taguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Taguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Taguchi. The network helps show where Eri Taguchi may publish in the future.

Co-authorship network of co-authors of Eri Taguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Taguchi. A scholar is included among the top collaborators of Eri Taguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Taguchi. Eri Taguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hasegawa, Maki, Eri Taguchi, Takeshi Kuboyama, et al.. (2019). In vivo activation of PEGylated long circulating lipid nanoparticle to achieve efficient siRNA delivery and target gene knock down in solid tumors. Journal of Controlled Release. 311-312. 245–256. 33 indexed citations
2.
3.
Shinmi, Daisuke, et al.. (2016). One-Step Conjugation Method for Site-Specific Antibody–Drug Conjugates through Reactive Cysteine-Engineered Antibodies. Bioconjugate Chemistry. 27(5). 1324–1331. 58 indexed citations
4.
Sawada, Norie, Eri Taguchi, & Motoko Takahashi. (2011). In vitro and in vivo activities of KRN330, a fully human monoclonal antibody against colon cancer.. Journal of Clinical Oncology. 29(4_suppl). 432–432. 3 indexed citations
5.
Berlin, Jordan, Jeffrey R. Infante, Eri Taguchi, et al.. (2010). Abstract 2431: In vivo antibody binding to tumor in xenograft rodent models and colorectal cancer patients treated with anti-A33 antibody KRN330. Cancer Research. 70(8_Supplement). 2431–2431. 3 indexed citations
6.
Taguchi, Eri, Kazuhide Nakamura, Toru Miura, Masabumi Shibuya, & Toshiyuki Isoe. (2008). Anti‐tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model. Cancer Science. 99(3). 623–630. 28 indexed citations
7.
Nakamura, Kazuhide, Eri Taguchi, Tsuyoshi Miura, et al.. (2006). KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties. Cancer Research. 66(18). 9134–9142. 164 indexed citations
8.
9.
Nakamura, Kazuhide, Atsushi Yamamoto, Masaru Kamishohara, et al.. (2004). KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. Molecular Cancer Therapeutics. 3(12). 1639–1649. 62 indexed citations
10.
Miyoshi, Chika, Eri Taguchi, & Norio Ohshima. (2003). Leukocyte Behavior in Angiogenic Vessels Is Affected by Tumor-Derived Nitric Oxide. The Japanese Journal of Physiology. 53(5). 343–350. 1 indexed citations
11.
Miyoshi, Chika, Eri Taguchi, & Norio Ohshima. (2001). Nitric Oxide Attenuates Leukocyte-Endothelial Cell Interactions in Tumor Microvessels. Microcirculation. 17. 143–144. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. C. Bendell Breakdown of academic impact, for papers by Sinto Sebastian Breakdown of academic impact, for papers by Christopher Montemagno Breakdown of academic impact, for papers by Atsushi Yawata Breakdown of academic impact, for papers by Michael W. Boesgaard Breakdown of academic impact, for papers by Jeffrey E. Lehr Breakdown of academic impact, for papers by Sean E. Sissons Breakdown of academic impact, for papers by Adrian Staab Breakdown of academic impact, for papers by Sandra Ictech Breakdown of academic impact, for papers by Amélie Petitprez
Rankless by CCL
2026